Find clinical trials for Multiple Sclerosis (MS) in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Sclerosis (MS) trials near Warszawa, Mazowieckie, POL:
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Warsaw, Poland and 50 other locations
This is a Phase 2 multicenter, double-blind, placebo-controlled, randomized, parallel-group trial to assess the efficacy and safety of 2 once-daily o...
Phase 2
Warszawa, Poland and 37 other locations
the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple...
Phase 3
Warsaw, Mazovia, Poland and 36 other locations
In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...
Phase 2
Warsaw, Poland and 78 other locations
(Part 1), a single-ascending subcutaneous (SC) dose (Part 2), and multiple ascending SC doses (Part 3) of RO7121932 in participants with multiple...
Phase 1
Warsaw, Poland and 31 other locations
This open label, single arm study will evaluate the PK and PD effects of fenebrutinib in children and adolescents with RMS aged between 10 and \< 18...
Phase 2
Warsaw, Poland and 15 other locations
This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...
Phase 3
Warsaw, Poland and 102 other locations
The goal of this clinical trial is to learn if drug CYB704, a proposed biosimilar to Ocrevus, works to treat multiple sclerosis in ...
Phase 3
Warsaw, Poland and 28 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...
Phase 3
Warsaw, Poland and 298 other locations
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...
Phase 3
Warsaw, Masovian Voivodeship, Poland and 354 other locations
Clinical trials
Research sites
Resources
Legal